| |
FOR IMMEDIATE RELEASE
Contact:
Steve McPhail
919-405-2248
smcphail@expressionanalysis.com
Expression Analysis, Inc. Hires Quality Assurance Director
Durham, NC – September 21, 2006 – Expression Analysis (EA), a full-service microarray testing, analysis and data management organization, has hired Raisa Lowe as Director of Quality Assurance. Raisa will be responsible for the implementation and management of quality initiatives at Expression Analysis, including continued compliance to Good Laboratory Practices (GLP), Good Clinical Practices (GCP) and compliance with the Clinical Laboratory Improvement Amendment (CLIA).
As Director of Quality Assurance, Raisa will also hold the responsibilities of writing, reviewing, and maintaining Standard Operating Procedures (SOPs) and laboratory protocols, maintaining equipment calibration, inspection and testing reports, reviewing laboratory batch records, and conducting pre-, mid-, and post- audits to assure data quality and integrity for final reporting.
Raisa comes to Expression Analysis with over nineteen years of experience in the biopharmaceutical industry. She has held quality assurance and compliance positions with such companies as Wellstat Biologics and Therapeutics, Diosynth RTP, Inc. (formerly Covance Biotechnology Services) and Compliance Quest, Inc. Raisa's extensive experience includes the implementation and maintenance of quality systems, preparation and evaluation of IND, NDA, and BLA submissions, along with the development and presentation of quality systems, batch records, and process validation programs to regulatory agencies. Raisa's education includes a B.S. in Biology from the Interamerican University of Puerto Rico and a M.S. in Biotechnology from Johns Hopkins University.
In describing her new position, Raisa said, “I am very excited to join Expression Analysis, which has an outstanding reputation for customer service, leadership, innovation and commitment to quality. I look forward to bringing my compliance experience to the company and making a positive and lasting impact on the organization and our clients.”
“We are delighted to add Raisa as the newest member of our management team,” said Steve McPhail, President and CEO of Expression Analysis, Inc. “Her experience in Quality Assurance, Regulatory Compliance and development of regulatory submissions will bring immediate value to our current client base and lay the foundation for future clinical diagnostic opportunities.”
About Expression Analysis
Expression Analysis, Inc., (EA) (www.expressionanalysis.com) is a full-service microarray genomics testing and analysis organization dedicated to providing clients with the highest quality genomic processing and data analysis services using Affymetrix GeneChip® brand technology. In 2004, EA became the first microarray services facility, worldwide, to provide GLP-compliant services. EA is a U.S.-based authorized service provider for Affymetrix (www.affymetrix.com), a California-based company that develops and commercializes systems to help researchers explore the relationship between genes and human health.
|
|
